LIMP-2 expression is critical for -glucocerebrosidase activity and -synuclein clearance
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LIMP-2 expression is critical for -glucocerebrosidase activity and -synuclein clearance
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 111, Issue 43, Pages 15573-15578
Publisher
Proceedings of the National Academy of Sciences
Online
2014-10-15
DOI
10.1073/pnas.1405700111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease
- (2014) Karen E. Murphy et al. BRAIN
- Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies
- (2014) Jose Bras et al. HUMAN MOLECULAR GENETICS
- Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease—Links to Parkinson’s Disease
- (2013) Laura D. Osellame et al. Cell Metabolism
- Is Parkinson disease associated with lysosomal integral membrane protein type-2?: Challenges in interpreting association data
- (2013) Emerson Maniwang et al. MOLECULAR GENETICS AND METABOLISM
- Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction
- (2013) Edward I. Ginns et al. MOLECULAR GENETICS AND METABOLISM
- The role ofSCARB2as susceptibility factor in Parkinson's disease
- (2013) Franziska Hopfner et al. MOVEMENT DISORDERS
- Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36
- (2013) Dante Neculai et al. NATURE
- The role of autophagy in neurodegenerative disease
- (2013) Ralph A Nixon NATURE MEDICINE
- Progressive myoclonus epilepsy: extraneuronal brown pigment deposition and system neurodegeneration in the brains of Japanese patients with novelSCARB2mutations
- (2013) Yong-Juan Fu et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies
- (2013) S. Pablo Sardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies
- (2013) Karen E Murphy et al. Acta Neuropathologica Communications
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
- (2012) Matthew E. Gegg et al. ANNALS OF NEUROLOGY
- Deficiency of ATP13A2 Leads to Lysosomal Dysfunction, -Synuclein Accumulation, and Neurotoxicity
- (2012) M. Usenovic et al. JOURNAL OF NEUROSCIENCE
- Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration
- (2012) B. Dehay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Critical Histidine Residue Within LIMP-2 Mediates pH Sensitive Binding to Its Ligand β-Glucocerebrosidase
- (2012) Christina Zachos et al. TRAFFIC
- Excess α-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1
- (2012) Derya R. Shimshek et al. Scientific Reports
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity
- (2011) David Ramonet et al. HUMAN MOLECULAR GENETICS
- A mutation in SCARB2 is a modifier in gaucher disease
- (2011) Arash Velayati et al. HUMAN MUTATION
- α-Synuclein Interacts with Glucocerebrosidase Providing a Molecular Link between Parkinson and Gaucher Diseases
- (2011) Thai Leong Yap et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models
- (2011) Y.H. Xu et al. MOLECULAR GENETICS AND METABOLISM
- Parkinson's disease and α-synuclein expression
- (2011) Michael J. Devine et al. MOVEMENT DISORDERS
- Neuropathology in Mice Expressing Mouse Alpha-Synuclein
- (2011) Claus Rieker et al. PLoS One
- Exploring the link between glucocerebrosidase mutations and parkinsonism
- (2011) Wendy Westbroek et al. TRENDS IN MOLECULAR MEDICINE
- Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease
- (2011) Chuong B. Do et al. PLoS Genetics
- Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome
- (2010) A. S. Al-Din et al. ACTA NEUROLOGICA SCANDINAVICA
- Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders
- (2010) Ozlem Goker-Alpan et al. ACTA NEUROPATHOLOGICA
- Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits
- (2010) Y. Sun et al. HUMAN MOLECULAR GENETICS
- Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease
- (2010) I. Ron et al. HUMAN MOLECULAR GENETICS
- Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease
- (2010) Suzanne Lesage et al. HUMAN MOLECULAR GENETICS
- Ultrasensitive in situ visualization of active glucocerebrosidase molecules
- (2010) Martin D Witte et al. Nature Chemical Biology
- Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy
- (2010) Kiren Ubhi et al. NEUROREPORT
- SCARB2mutations in progressive myoclonus epilepsy (PME) without renal failure
- (2009) L.M. Dibbens et al. ANNALS OF NEUROLOGY
- Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand β-glucocerebrosidase
- (2009) Judith Blanz et al. HUMAN MOLECULAR GENETICS
- Specific saposin C deficiency: CNS impairment and acid -glucosidase effects in the mouse
- (2009) Y. Sun et al. HUMAN MOLECULAR GENETICS
- Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism
- (2009) Amy B. Manning-Boğ et al. NEUROTOXICOLOGY
- Array-Based Gene Discovery with Three Unrelated Subjects Shows SCARB2/LIMP-2 Deficiency Causes Myoclonus Epilepsy and Glomerulosclerosis
- (2008) Samuel F. Berkovic et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Cathepsin D Is the Main Lysosomal Enzyme Involved in the Degradation of α-Synuclein and Generation of Its Carboxy-Terminally Truncated Species†
- (2008) Daniel Sevlever et al. BIOCHEMISTRY
- Reversal of peripheral and central neural storage and ataxia after recombinant enzyme replacement therapy in α-mannosidosis mice
- (2008) Judith Blanz et al. HUMAN MOLECULAR GENETICS
- A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome
- (2008) A. Balreira et al. HUMAN MOLECULAR GENETICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started